Release date: March 4, 2026
Expiration date: March 3, 2028
Estimated Time of Completion: 1 hour
Webcast Agenda
Salmon patch?
Soumaya Bohout, MD
Cbd mass in a child
Mathew Henderson, MD
Translucent iris tumor
Arun D. Singh, MD
Three vs 6 Cycles of Chemotherapy for High-Risk Retinoblastoma
Stacey Zahler, DO
Description
Watch Ocular Oncology and Pathology Webcasts, an on-demand and complimentary series repurposed from Cole Eye’s Ocular Oncology and Pathology Grand Rounds.
Learning Objectives
- Evaluate the most appropriate diagnostic modality.
- Formulate a treatment plan.
- Identify unusual oncologic disorders.
- Synthesize a diagnosis.
Target Audience
This education is designed for hematologists, oncologists, ophthalmologists, pathologists, and pediatricians.
Accreditation
In support of improving patient care, Cleveland Clinic Center for Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians / American Medical Association (AMA)
Cleveland Clinic Center for Continuing Education designates this internet enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.
Certificate of Participation
A certificate of participation will be provided to other health care professionals for requesting credits in accordance with their professional boards and/or associations.
Activity Director and Faculty
Activity Directors
Arun Singh, MD
Cleveland Clinic
Cleveland, OH
Elias Traboulsi, MD, MEd
Cleveland Clinic
Cleveland, OH
Faculty
Soumaya Bouhout, MD
Matthew Henderson, MD
Tatyana Milman, MD
Gabrielle Yeaney, MD
Stacey Zahler, DO
CME Disclaimer
The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.
Disclosures
In accordance with the Standards for Integrity and Independence issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Center for Continuing Education mitigates all relevant faculty conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty has indicated that they may have a relationship, which in the context of their presentation(s) could be perceived as a potential conflict of interest:
Arun Singh, MD: Aura Biosciences - Consulting, Advisor or review panel participant. Castle Biosciences -
Consulting. Isoaid LLC - Consulting. Ideaya Biosciences - Consulting. Immunocore LLC – Consulting
Stacey Zahler, DO: US World Meds - Advisor or review panel participant (Ended: 03/25/2025).
All other individuals have indicated no relationship which, in the context of their involvement, could be perceived as a potential conflict of interest.
This CME activity was produced by the Cleveland Clinic Foundation Center for Continuing Education and Cleveland Clinic’s Cole Eye.
